Walleye Trading
RCUS icon

Walleye Trading’s Arcus Biosciences RCUS Stock Holding History

Walleye Trading’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,600
Closed -$38.1K – 4597
2025
Q4 		$38.1K Buy
+1,600
New +$32.6K ﹤0.01% 4009
2024
Q1 		– Sell
-30,400
Closed -$581K – 5234
2023
Q4 		$581K Sell
30,400
-23,800
-44% -$380K ﹤0.01% 2950
2023
Q3 		$973K Sell
54,200
-25,200
-32% -$506K ﹤0.01% 2388
2023
Q2 		$1.61M Buy
79,400
+70,400
+782% +$1.34M ﹤0.01% 1811
2023
Q1 		$164K Buy
+9,000
New +$172K ﹤0.01% 3640
2021
Q3 		– Sell
-1,700
Closed -$47K – 5613
2021
Q2 		$47K Buy
+1,700
New +$48.6K ﹤0.01% 4648

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Walleye Trading's RCUS Position: Q1 2024 in Review

Walleye Trading sold out of Arcus Biosciences (RCUS) in Q1 2024, closing a stake of 32,251 shares — an estimated $616K sold.

Walleye Trading first reported a position in RCUS in Q2 2021 and held it in 5 quarters. The position peaked at $1.55M in Q2 2023. 172 funds tracked by Wall St. Rank hold RCUS as of Q1 2024.

  • Walleye Trading reported no remaining Arcus Biosciences position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 32,251 Arcus Biosciences shares in Q1 2024, an estimated $616K.
  • Walleye Trading first reported a position in Arcus Biosciences in Q2 2021 and held it in 5 quarters.
  • Walleye Trading's Arcus Biosciences position peaked at $1.55M in Q2 2023.
  • 172 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.